Hemophagocytic lymphohistiocytosis (HLH) is a rare disorder of immune dysregulation, characterized by end-organ damage from lymphocytic infiltration and macrophage activation.
Introduction
HLH is a rare disease in which the immune system becomes overactive due to its inability to effectively clear infections, and/or regulate its response to infections. [1] [2] [3] Despite aggressive chemotherapeutic interventions, patients with HLH have a high mortality rate due to end-organ damage. All of the known mutations associated with HLH are in genes involved in the granule exocytosis pathway (e.g., Perforin, SAP, Munc13-4, Rab27a, CHS-1, and others), implicating the critical role of this pathway in controlling immune responses to infections. [4] [5] [6] [7] We report two cases of HLH in HHV-8 infected triplets, both having novel compound heterozygous mutations in the Perforin gene and absent NK cell function. To our knowledge, this is the first report of triplets presenting with HLH, and are the first non-HIV and non-renal transplant subjects that have developed HLH in association with HHV-8 infection.
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Materials and Methods
Subject
Flow Cytometry Analysis.
Peripheral blood mononuclear cells (PBMC) were stained for surface and intracellular markers as previously described. 8 Briefly, whole blood was stained with surface antibodies (CD4, CD8 and CD56; Becton Dickinson), then fixed, permeabilized (Cytofix/Cytoperm; Pharmingen), and stained with primary-conjugated anti-granzyme A (CB9; Becton Dickinson-Pharmingen), anti-granzyme B (GB12; Caltag), and anti-perforin ( G9; Becton Dickinson-Pharmingen) antibodies. Samples were analyzed on a FACSCalibur (Becton Dickinson).
Flow-Based Killing Assay.
A flow-based killing assay was performed as previously described. 8 Briefly, K562 target cells were labeled with 125 nM of 5-(and-6-)-carboxyfluorescein diacetate succinimydyl ester (Molecular Probes), and then mixed and plated with isolated subject PBMCs Nested PCR for HHV-8. Nested PCR for HHV-8 was performed as previously described. 9, 10 Briefly, DNA was isolated from each subject sample (DNeasy; Qiagen), then the HHV-8 specific 336 bp ORF-26 region (nucleotide position 890 to 1226) was amplified by nested PCR using an outside primer pair (5'-ATCTATCCAAGTGCACACTGC-3' and 5'-CTGGGAACCAAGGCTGATAGG-3') and an inside primer pair (5'-GATGATCCCTCTGACAACCT-3' and 5'-GGATCCGTGTTGTCTACG-3'). The product of the nested PCR was resolved on a 1.5% agarose gel. The BC-3 and Mewo cell lines were used for positive and negative controls, respectively.
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Results and Discussion
Case Report-A A four-month-old multiethnic girl (Triplet A; sister to triplets B & C) was transferred to our institution for persistent fevers and pancytopenia. Birth history was remarkable for delivery at 29 weeks, and Group B streptococcus septicemia at four weeks of age. Family history was unremarkable, and the parents were not related. Physical examination upon presentation Figure 1B ).
Similar to Triplet A, she had no detectable perforin antibody reactivity and minimal NK cell killing ( Figure 1B and 1D) . 8 The clinical diagnosis of HLH was made, and she was started on HLH-94 therapy with subsequent improvement in her blood counts and serum chemistries.
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For A & B) having HLH. Physical examination was unremarkable. All laboratory tests were within normal limits. Genetic analysis showed that she was a carrier of a single mutated Perforin allele, similar to her father's mutation (Figure 2A ). She has required no further medical intervention.
These case reports are to our knowledge the first cases of HLH occurring in a set of triplets.
There have been two previous reports of Perforin gene mutations in twins. 13, 14 Twins reported by Lipton et al. presented in the newborn period with symptoms consistent with HLH. 14 Genetic analysis demonstrated a single missense mutation in the Peforin gene in only one of the twins and their mother. It was presumed that each twin inherited an additional genetic mutation in the Perforin gene from their father; however, this point was not documented. 14 Busiello et al.
reported on two fraternal twins having the same homozygous Perforin mutations. 13 Despite both twins having the same Perforin mutations, only one reportedly developed HLH. The unaffected twin reportedly demonstrated normal NK cell activity. 13 In our study, the affected triplets presented within 12-weeks of each other following a viral prodrome. HHV-8 infection was documented by PCR amplification in both subjects using a previously published technique. 10 HHV-8 was noted in the peripheral blood of Triplet A, but not her CSF, while Triplet B only had HHV-8 detected in her CSF. These differences are probably related to the timing of sample collections from each of the two subjects. The source of the HHV-8 infection is difficult to discern; however, since a small percentage of healthy American adults are HHV-8 seropositive, one possibility is transmission via a blood product while in the nursery. 15 Although HLH has been previously associated with HHV-8 infection, all of these reports have been in HIV infected individuals with associated Kaposi's sarcoma, [16] [17] [18] or renal transplant patients. 19, 20 Genetic analysis demonstrated that triplets A and B had the same compound These results suggest that despite having the same genetic mutations, there are significant polygenetic influences in the development of HLH.
This report and others demonstrate the critical importance of the perforin/granzyme pathway in NK cell function and viral clearance. Moreover, it stresses the importance of this pathway in regulating immune responses to viral infections. We have recently reported that human T regulatory cells also utilize the perforin/granzyme pathway. We demonstrated that both adaptive and natural human T regulatory cells are able to 'suppress' autologous naïve T cell proliferation by killing them through the perforin/granzyme pathway. 3, 8 These reports support the important role that this pathway plays in the immune dysregulation found in HLH.
Specifically, they demonstrate that the perforin/granzyme pathway is not only important in the initial immune response to viral infections, but that it is also a pathway used in regulating or 
